Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 4
1989 6
1990 7
1991 5
1992 18
1993 45
1994 81
1995 141
1996 209
1997 184
1998 226
1999 285
2000 304
2001 314
2002 431
2003 393
2004 476
2005 539
2006 548
2007 617
2008 569
2009 500
2010 563
2011 562
2012 544
2013 536
2014 483
2015 484
2016 518
2017 461
2018 432
2019 400
2020 407
2021 344
Text availability
Article attribute
Article type
Publication date

Search Results

10,583 results
Results by year
Filters applied: . Clear all
Page 1
Comparative Pharmacology of Risperidone and Paliperidone.
Corena-McLeod M. Corena-McLeod M. Drugs R D. 2015 Jun;15(2):163-74. doi: 10.1007/s40268-015-0092-x. Drugs R D. 2015. PMID: 25943458 Free PMC article. Review.
Antipsychotics, risperidone, and risperidone's active metabolite, paliperidone (9-hydroxyrisperidone), are related molecules used for the treatment of schizophrenia and related disorders. ...This review seeks to explore the most significant differences at the molecu …
Antipsychotics, risperidone, and risperidone's active metabolite, paliperidone (9-hydroxyrisperidone), are related molecules u …
Risperidone.
Germann D, Kurylo N, Han F. Germann D, et al. Profiles Drug Subst Excip Relat Methodol. 2012;37:313-61. doi: 10.1016/B978-0-12-397220-0.00008-8. Epub 2012 Mar 19. Profiles Drug Subst Excip Relat Methodol. 2012. PMID: 22469322 Review. No abstract available.
Classics in Chemical Neuroscience: Risperidone.
Chopko TC, Lindsley CW. Chopko TC, et al. ACS Chem Neurosci. 2018 Jul 18;9(7):1520-1529. doi: 10.1021/acschemneuro.8b00159. Epub 2018 May 11. ACS Chem Neurosci. 2018. PMID: 29695153 Review.
Despite initial Food and Drug Administration approval 25 years ago, risperidone continues to be a fundamental treatment for schizophrenia, bipolar I disorder, and autism-related irritability. ...In this review, we highlight the history and importance of risperidone
Despite initial Food and Drug Administration approval 25 years ago, risperidone continues to be a fundamental treatment for schizophr …
Haloperidol, risperidone, olanzapine and aripiprazole in the management of delirium: A comparison of efficacy, safety, and side effects.
Boettger S, Jenewein J, Breitbart W. Boettger S, et al. Palliat Support Care. 2015 Aug;13(4):1079-85. doi: 10.1017/S1478951514001059. Epub 2014 Sep 5. Palliat Support Care. 2015. PMID: 25191793 Free article.
RESULTS: The baseline characteristics of the medication groups were not different: The mean age of the patients ranged from 64.0 to 69.6 years, dementia was present in between 23.8 and 28.6%, and baseline MDAS scores were 19.9 (haloperidol), 18.6 (risperidone), 19.4 (olanz …
RESULTS: The baseline characteristics of the medication groups were not different: The mean age of the patients ranged from 64.0 to 69.6 yea …
Newer Formulations of Risperidone: Role in the Management of Psychotic Disorders.
Clark I, Taylor D. Clark I, et al. CNS Drugs. 2020 Aug;34(8):841-852. doi: 10.1007/s40263-020-00735-3. CNS Drugs. 2020. PMID: 32462508 Review.
Antipsychotic long-acting injections improve relapse prevention in psychotic disorders. Three new risperidone formulations have been developed that offer advantages over currently available risperidone-based long-acting injections. Risperidone ISM() is a mont …
Antipsychotic long-acting injections improve relapse prevention in psychotic disorders. Three new risperidone formulations have been …
Long-acting injectable risperidone.
Ehret MJ, Fuller MA. Ehret MJ, et al. Ann Pharmacother. 2004 Dec;38(12):2122-7. doi: 10.1345/aph.1E085. Epub 2004 Nov 2. Ann Pharmacother. 2004. PMID: 15522979 Review.
DATA SYNTHESIS: Risperidone LA is the first long-acting, injectable atypical antipsychotic. ...CONCLUSIONS: Risperidone LA is efficacious and safe in the treatment of schizophrenia....
DATA SYNTHESIS: Risperidone LA is the first long-acting, injectable atypical antipsychotic. ...CONCLUSIONS: Risperidone LA is …
Long-acting risperidone injection.
Love RC, Conley RJ. Love RC, et al. Am J Health Syst Pharm. 2004 Sep 1;61(17):1792-800. doi: 10.1093/ajhp/61.17.1792. Am J Health Syst Pharm. 2004. PMID: 15462250 Review.
PURPOSE: The pharmacology, pharmaceutics, clinical efficacy, adverse effects, cost, and dosage and administration of long-acting risperidone injection are reviewed. SUMMARY: Risperidone is the first atypical antipsychotic available in a long-acting injectable formul …
PURPOSE: The pharmacology, pharmaceutics, clinical efficacy, adverse effects, cost, and dosage and administration of long-acting risperid
Risperidone for bipolar disorders.
Sajatovic M, Madhusoodanan S, Fuller MA, Aulakh L, Keaton DB. Sajatovic M, et al. Expert Rev Neurother. 2005 Mar;5(2):177-87. doi: 10.1586/14737175.5.2.177. Expert Rev Neurother. 2005. PMID: 15853488 Review.
Risperidone has also been reported to be useful in the longer-term treatment of bipolar disorder. This drug profile of risperidone for bipolar disorder will address the chemistry, pharmacodynamics, pharmacokinetics and metabolism of risperidone, clinical tria
Risperidone has also been reported to be useful in the longer-term treatment of bipolar disorder. This drug profile of risperidone
Risperidone alone or in combination for acute mania.
Rendell JM, Gijsman HJ, Bauer MS, Goodwin GM, Geddes GR. Rendell JM, et al. Cochrane Database Syst Rev. 2006 Jan 25;2006(1):CD004043. doi: 10.1002/14651858.CD004043.pub2. Cochrane Database Syst Rev. 2006. PMID: 16437472 Free PMC article. Review.
BACKGROUND: Risperidone, an atypical antipsychotic, is used to treat mania both alone and in combination with other medicines. ...The acceptability of risperidone and haloperidol in incidence of failure to complete treatment was comparable. ...
BACKGROUND: Risperidone, an atypical antipsychotic, is used to treat mania both alone and in combination with other medicines. ...The …
CYP2D6 Genotype-Based Dose Recommendations for Risperidone in Asian People.
Cui Y, Yan H, Su Y, Wang L, Lu T, Zhang D, Yue W. Cui Y, et al. Front Pharmacol. 2020 Aug 4;11:936. doi: 10.3389/fphar.2020.00936. eCollection 2020. Front Pharmacol. 2020. PMID: 32848719 Free PMC article.
First, we investigated the influence of CYP2D6 polymorphism on the pharmacokinetics of risperidone in Chinese patients with schizophrenia. Then, we performed a search for studies covering the relationship between pharmacokinetic parameters of risperidone and CYP2D6 …
First, we investigated the influence of CYP2D6 polymorphism on the pharmacokinetics of risperidone in Chinese patients with schizophr …
10,583 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page